Clinical Trial Update: Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at UT Southwestern is investigating single-cell immune and non-immune biomarkers related to response to neoadjuvant abemaciclib in brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING